About [3-(4,4-dimethylcyclohexyl)-4-[(3S)-pyrrolidin-1-ium-3-yl]oxyphenyl]-[4-(3-fluoro-5-piperazin-4-ium-1-ylbenzoyl)piperazin-1-yl]methanone
[3-(4,4-dimethylcyclohexyl)-4-[(3S)-pyrrolidin-1-ium-3-yl]oxyphenyl]-[4-(3-fluoro-5-piperazin-4-ium-1-ylbenzoyl)piperazin-1-yl]methanone (PubChem CID 162446136) has the molecular formula C34H48FN5O3+2
and a molecular weight of 593.79 g/mol. Its IUPAC name is [3-(4,4-dimethylcyclohexyl)-4-[(3S)-pyrrolidin-1-ium-3-yl]oxyphenyl]-[4-(3-fluoro-5-piperazin-4-ium-1-ylbenzoyl)piperazin-1-yl]methanone.
Molecular Properties
| Compound Name | [3-(4,4-dimethylcyclohexyl)-4-[(3S)-pyrrolidin-1-ium-3-yl]oxyphenyl]-[4-(3-fluoro-5-piperazin-4-ium-1-ylbenzoyl)piperazin-1-yl]methanone |
| PubChem CID | 162446136 |
| Molecular Formula | C34H48FN5O3+2 |
| Molecular Weight | 593.79 g/mol |
| Exact Mass | 593.37 |
| IUPAC Name | [3-(4,4-dimethylcyclohexyl)-4-[(3S)-pyrrolidin-1-ium-3-yl]oxyphenyl]-[4-(3-fluoro-5-piperazin-4-ium-1-ylbenzoyl)piperazin-1-yl]methanone |
| SMILES | CC1(C)CCC(c2cc(C(=O)N3CCN(C(=O)c4cc(F)cc(N5CC[NH2+]CC5)c4)CC3)ccc2O[C@H]2CC[NH2+]C2)CC1 |
| InChI | InChI=1S/C34H46FN5O3/c1-34(2)8-5-24(6-9-34)30-21-25(3-4-31(30)43-29-7-10-37-23-29)32(41)39-15-17-40(18-16-39)33(42)26-19-27(35)22-28(20-26)38-13-11-36-12-14-38/h3-4,19-22,24,29,36-37H,5-18,23H2,1-2H3/p+2/t29-/m0/s1 |
| InChIKey | NHHZZMQXCFCORB-LJAQVGFWSA-P |
| XLogP | 2.21 |
| TPSA | 86.31 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 43 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 593.79 |
| LogP ≤ 5 | 2.21 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Analyze [3-(4,4-dimethylcyclohexyl)-4-[(3S)-pyrrolidin-1-ium-3-yl]oxyphenyl]-[4-(3-fluoro-5-piperazin-4-ium-1-ylbenzoyl)piperazin-1-yl]methanone with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of [3-(4,4-dimethylcyclohexyl)-4-[(3S)-pyrrolidin-1-ium-3-yl]oxyphenyl]-[4-(3-fluoro-5-piperazin-4-ium-1-ylbenzoyl)piperazin-1-yl]methanone?
The IUPAC name of [3-(4,4-dimethylcyclohexyl)-4-[(3S)-pyrrolidin-1-ium-3-yl]oxyphenyl]-[4-(3-fluoro-5-piperazin-4-ium-1-ylbenzoyl)piperazin-1-yl]methanone (CID 162446136) is [3-(4,4-dimethylcyclohexyl)-4-[(3S)-pyrrolidin-1-ium-3-yl]oxyphenyl]-[4-(3-fluoro-5-piperazin-4-ium-1-ylbenzoyl)piperazin-1-yl]methanone.
What is the SMILES notation for [3-(4,4-dimethylcyclohexyl)-4-[(3S)-pyrrolidin-1-ium-3-yl]oxyphenyl]-[4-(3-fluoro-5-piperazin-4-ium-1-ylbenzoyl)piperazin-1-yl]methanone?
The canonical SMILES for [3-(4,4-dimethylcyclohexyl)-4-[(3S)-pyrrolidin-1-ium-3-yl]oxyphenyl]-[4-(3-fluoro-5-piperazin-4-ium-1-ylbenzoyl)piperazin-1-yl]methanone is CC1(C)CCC(c2cc(C(=O)N3CCN(C(=O)c4cc(F)cc(N5CC[NH2+]CC5)c4)CC3)ccc2O[C@H]2CC[NH2+]C2)CC1.
What is the InChIKey of [3-(4,4-dimethylcyclohexyl)-4-[(3S)-pyrrolidin-1-ium-3-yl]oxyphenyl]-[4-(3-fluoro-5-piperazin-4-ium-1-ylbenzoyl)piperazin-1-yl]methanone?
The InChIKey is NHHZZMQXCFCORB-LJAQVGFWSA-P. The full InChI is InChI=1S/C34H46FN5O3/c1-34(2)8-5-24(6-9-34)30-21-25(3-4-31(30)43-29-7-10-37-23-29)32(41)39-15-17-40(18-16-39)33(42)26-19-27(35)22-28(20-26)38-13-11-36-12-14-38/h3-4,19-22,24,29,36-37H,5-18,23H2,1-2H3/p+2/t29-/m0/s1.
What are the key properties of [3-(4,4-dimethylcyclohexyl)-4-[(3S)-pyrrolidin-1-ium-3-yl]oxyphenyl]-[4-(3-fluoro-5-piperazin-4-ium-1-ylbenzoyl)piperazin-1-yl]methanone?
[3-(4,4-dimethylcyclohexyl)-4-[(3S)-pyrrolidin-1-ium-3-yl]oxyphenyl]-[4-(3-fluoro-5-piperazin-4-ium-1-ylbenzoyl)piperazin-1-yl]methanone has a molecular weight of 593.79 g/mol, XLogP of 2.21, 6 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for [3-(4,4-dimethylcyclohexyl)-4-[(3S)-pyrrolidin-1-ium-3-yl]oxyphenyl]-[4-(3-fluoro-5-piperazin-4-ium-1-ylbenzoyl)piperazin-1-yl]methanone is sourced from PubChem (CID 162446136), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).